CN103142987B - Medicament for treating mumps - Google Patents

Medicament for treating mumps Download PDF

Info

Publication number
CN103142987B
CN103142987B CN201310111447.1A CN201310111447A CN103142987B CN 103142987 B CN103142987 B CN 103142987B CN 201310111447 A CN201310111447 A CN 201310111447A CN 103142987 B CN103142987 B CN 103142987B
Authority
CN
China
Prior art keywords
parts
herba
radix
rhizoma
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201310111447.1A
Other languages
Chinese (zh)
Other versions
CN103142987A (en
Inventor
胡荣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hu Rong
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310111447.1A priority Critical patent/CN103142987B/en
Publication of CN103142987A publication Critical patent/CN103142987A/en
Application granted granted Critical
Publication of CN103142987B publication Critical patent/CN103142987B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicament for treating mumps. The medicament is prepared from the following substances in parts by weight: 5-10 parts of radix scrophulariae, 10-20 parts of rhizoma zingiberis, 20-30 parts of dogwood, 10-20 parts of platycodon grandiflorum, 15-25 parts of goldthread, 5-15 parts of chrysanthemum, 10-30 parts of golden-rod, 1-15 parts of henbane, 10-20 parts of ephedra, 15-30 parts of pyrrosia lingua, 20-30 parts of magnolia flower, 1-20 parts of morinda officinalis, 1-20 parts of celandine, 10-25 parts of lalang grass rhizome, 10-30 parts of cocklebur fruit, 1-20 parts of emblic leafflower fruit, 15-20 parts of kamuning, 10-20 parts of eucommia ulmoides, 15-20 parts of herba inulae, 15-30 parts of herb of glabrous sarcandra, 10-20 parts of fructus aristolochiae, 10-25 parts of folium sennae, 5-15 parts of aleppo avens, 1-20 parts of uniflower swisscentaury root, 15-25 parts of rhododendron dauricum, 15-25 parts of potentilla discolor, 10-20 parts of chinese lantern-plant, 15-25 parts of rhizoma cimicifugae, 20-30 parts of lindley eupatorium, 1-20 parts of gorgon fruit and 10-25 parts of China rose. All components of the medicament for treating mumps disclosed by the invention are natural materials; and the medicament is good in security, definite in curative effect, and suitable for large-scale clinical popularization.

Description

A kind of medicament for the treatment of mumps
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of medicament for the treatment of mumps.
Background technology
Mumps is called for short the stream cheek, also claims mumps, is commonly called as " pig's head is crazy ", " mumps ", " to rumor " etc., is that spring is common, is also respiratory infectious disease common in child and teenager, is also found in adult.It is to invade by mumps virus the acute respiration infectious disease that the parotid gland causes, and can invade the organs such as various glandular tissues or nervous system and liver, kidney, heart, joint, and patient is the source of infection, and the suction of the spittle is main route of transmission, 2-3 week morbidity after contact patient.Parotitis main manifestations is enlargement under the ear-lobe of one or both sides, and the parotid gland of enlargement is often hemispherical, blur margin centered by ear-lobe, and surface heat has angle pain, and when dehiscing or chewing, pain is felt in part.Searching for the medicament of new treatment mumps never stops.
Summary of the invention
The object of this invention is to provide a kind of medicament for the treatment of mumps.
In order to realize object of the present invention, the invention provides a kind of medicament for the treatment of mumps, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Rhizoma Coptidis 15-25 part, Flos Chrysanthemi 5-15 part, Herba Solidaginis 10-30 part, Semen Hyoscyami 1-15 part, Herba Ephedrae 10-20 part, Folium Pyrrosiae 15-30 part, Flos Magnoliae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Chelidonii 1-20 part, Rhizoma Imperatae 10-25 part, Fructus Xanthii 10-30 part, Fructus Phyllanthi 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Cortex Eucommiae 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Rhapontici 1-20 part, Radix Achyranthis Bidentatae 15-25 part, Herba Potentillae Discoloris 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Rhizoma Cimicifugae 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Semen Euryales 1-20 part and Flos Rosae Chinensis 10-25 part.
Preferably, the medicament for the treatment of mumps of the present invention is to be made by the material of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of Rhizoma Coptidis, 13 parts of Flos Chrysanthemis, 28 parts of Herba Solidaginiss, 11 parts of Semen Hyoscyamis, 17 parts, Herba Ephedrae, 24 parts of Folium Pyrrosiaes, 27 parts of Flos Magnoliaes, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Chelidoniis, 23 parts of Rhizoma Imperataes, 21 parts of Fructus Xanthii, 16 parts of Fructus Phyllanthis, 16 parts of Folium Et Cacumen Murrayae, 17 parts of the Cortexs Eucommiae, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Herba Clinopodii, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Radix Rhapontici, 23 parts of Radix Achyranthis Bidentataes, 24 parts of Herba Potentillae Discoloris, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Rhizoma Cimicifugaes, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Semen Euryaless and Flos Rosae Chinensiss.
More preferably, described medicament can be tablet, dispersible tablet, capsule or decoction.
Whole compositions of the medicament for the treatment of mumps of the present invention are all natural materials, and safety is better, and curative effect is clear and definite, are suitable for large-scale promotion clinically.
The specific embodiment
Below by embodiment, further illustrate the present invention.It should be understood that embodiments of the invention are for the present invention rather than limitation of the present invention are described.The simple modifications that essence according to the present invention is carried out the present invention all belongs to the scope of protection of present invention.Except as otherwise noted, the percent otherwise in the present invention is percetage by weight.
Embodiment decoction of the present invention
Take 7 grams of Radix Scrophulariaes, 13 grams of Rhizoma Zingiberiss, 22 grams of Fructus Corni, 15 grams of Radix Platycodoniss, 21 grams of Rhizoma Coptidis, 13 grams of Flos Chrysanthemis, 28 grams of Herba Solidaginiss, 11 grams of Semen Hyoscyamis, 17 grams, Herba Ephedrae, 24 grams of Folium Pyrrosiaes, 27 grams of Flos Magnoliaes, 18 grams of Radix Morindae Officinaliss, 17 grams of Herba Chelidoniis, 23 grams of Rhizoma Imperataes, 21 grams of Fructus Xanthii, 16 grams of Fructus Phyllanthis, 16 grams of Folium Et Cacumen Murrayae, 17 grams of the Cortexs Eucommiae, 19 grams of Herba Inulae, 15 grams of Herba Sarcandraes, 14 grams of Herba Clinopodii, 21 grams of Folium Sennae, 11 grams of Radix seu Herba Gei aleppici, 13 grams of Radix Rhapontici, 23 grams of Radix Achyranthis Bidentataes, 24 grams of Herba Potentillae Discoloris, 14 grams of Calyx Seu Fructus Physaliss, 25 grams of Rhizoma Cimicifugaes, 26 grams of Herba Eupatorii Lindleyanis, 24 grams of 16 grams of Semen Euryaless and Flos Rosae Chinensiss, add 2000 milliliters, water, in being housed, at 80 ℃, heats 4 hours by the flask of condensing tube, filter.Filtrate is concentrated into 600 milliliters, obtains decoction of the present invention.
Experimental example
Diagnostic criteria
The national higher medical teaching material < < of the academy pediatrics > > mumps diagnostic criteria formulation of reference (Wang Mudi, pediatrics [M] .5 version. Beijing: People's Health Publisher, 2002:201-202.): 1. epidemiology contact history, all can fall ill throughout the year, but common with early spring in winter evening.2. body temperature moderate increases, headache, myalgia etc.3. the lower adenoncus of parotid gland enlargement or neck, tenderness.4. the accidental red pimple of trunk or urticaria.5. separablely from infant saliva, urine or blood go out parotid gland virus.
Choose 50 routine infants, male 25 examples, female's 25 examples; 2 months-5 years old age, 3.8 years old mean age.
Use the decoction of preparing in embodiment to treat, every day 2 times, each oral 50 milliliters.Treatment 3 days is 1 course for the treatment of continuously.
Treatment standard is as follows
Cure: body temperature is down to normally, headache, myalgia disappear, and parotid gland swelling and pain disappears.Effective: body temperature obviously declines, parotid gland swelling and pain obviously alleviates.Effective: body temperature declines to some extent, parotid gland swelling and pain is alleviated.Invalid: body temperature continues to increase, parotid gland swelling and pain is not alleviated or is increased the weight of.
Therapeutic outcome
After treating 1 course for the treatment of, all infants all meet the standard of healing, and do not observe obvious untoward reaction.

Claims (2)

1. a medicament for the treatment of mumps, it is characterized in that, it is to be made by the raw material of Chinese medicine of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Rhizoma Coptidis 15-25 part, Flos Chrysanthemi 5-15 part, Herba Solidaginis 10-30 part, Semen Hyoscyami 1-15 part, Herba Ephedrae 10-20 part, Folium Pyrrosiae 15-30 part, Flos Magnoliae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Chelidonii 1-20 part, Rhizoma Imperatae 10-25 part, Fructus Xanthii 10-30 part, Fructus Phyllanthi 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Cortex Eucommiae 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Rhapontici 1-20 part, Radix Achyranthis Bidentatae 15-25 part, Herba Potentillae Discoloris 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Rhizoma Cimicifugae 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Semen Euryales 1-20 part and Flos Rosae Chinensis 10-25 part.
2. the medicament for the treatment of mumps according to claim 1, it is characterized in that, it is to be made by the raw material of Chinese medicine of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of Rhizoma Coptidis, 13 parts of Flos Chrysanthemis, 28 parts of Herba Solidaginiss, 11 parts of Semen Hyoscyamis, 17 parts, Herba Ephedrae, 24 parts of Folium Pyrrosiaes, 27 parts of Flos Magnoliaes, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Chelidoniis, 23 parts of Rhizoma Imperataes, 21 parts of Fructus Xanthii, 16 parts of Fructus Phyllanthis, 16 parts of Folium Et Cacumen Murrayae, 17 parts of the Cortexs Eucommiae, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Herba Clinopodii, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Radix Rhapontici, 23 parts of Radix Achyranthis Bidentataes, 24 parts of Herba Potentillae Discoloris, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Rhizoma Cimicifugaes, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Semen Euryaless and Flos Rosae Chinensiss.
CN201310111447.1A 2013-03-22 2013-03-22 Medicament for treating mumps Expired - Fee Related CN103142987B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310111447.1A CN103142987B (en) 2013-03-22 2013-03-22 Medicament for treating mumps

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310111447.1A CN103142987B (en) 2013-03-22 2013-03-22 Medicament for treating mumps

Publications (2)

Publication Number Publication Date
CN103142987A CN103142987A (en) 2013-06-12
CN103142987B true CN103142987B (en) 2014-02-05

Family

ID=48541497

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310111447.1A Expired - Fee Related CN103142987B (en) 2013-03-22 2013-03-22 Medicament for treating mumps

Country Status (1)

Country Link
CN (1) CN103142987B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103893601B (en) * 2014-04-17 2016-04-27 李俊瑶 A kind of medicament for the treatment of mumps
CN104352640A (en) * 2014-11-22 2015-02-18 邹士东 Pharmaceutical composition for treating parotitis
CN105748574A (en) * 2016-05-17 2016-07-13 李晓维 Traditional Chinese medicine for treating angina parotidea

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102058720A (en) * 2010-12-24 2011-05-18 郑国静 Chinese medical cataplasm for treating epidemic mumps

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102058720A (en) * 2010-12-24 2011-05-18 郑国静 Chinese medical cataplasm for treating epidemic mumps

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
中西医综合治疗流行性腮腺炎临床体会;陈吉兵;《中国社区医师·医学专业》;20100131;第12卷(第总227期);86 *
陈吉兵.中西医综合治疗流行性腮腺炎临床体会.《中国社区医师·医学专业》.2010,第12卷(第总227期),86.

Also Published As

Publication number Publication date
CN103142987A (en) 2013-06-12

Similar Documents

Publication Publication Date Title
CN101690745B (en) Chinese medicinal composition for preventing and treating flu
CN102319294A (en) Double-vanilla preparation and preparation method thereof
CN103142987B (en) Medicament for treating mumps
CN102139051B (en) Application of soft capsule capable of clearing heat and eliminating toxin in preparation of medicament for treating viral pneumonia
CN103142982A (en) Medicine for treating acute upper respiratory infection
CN116139237B (en) A Chinese medicinal composition for preventing and treating respiratory tract infection caused by coronavirus, and its application
CN101507743A (en) Biennial wormwood extract and preparation method thereof
CN1326552C (en) Medicine for treating viral influenza, and its prepn. method
CN101683429A (en) Animal Chinese medicine granular formulation for preventing and treating infectious bursal disease of fowl and preparation method thereof
CN103142981A (en) Medicament for treating mammitis
CN103142974B (en) Medicament for treating anxiety disorder
CN102488802B (en) Medicament for treating epidemic parotitis
CN103191385B (en) Medicament for treating infantile asthma
CN103142983B (en) Medicament for treating chronic pharyngitis
CN102727589B (en) Medicament for treating cough with lung heat of children
CN107519265A (en) One kind flu patch and preparation method thereof
CN105250774A (en) Traditional Chinese medicine composition for treating chronic influenza
CN101049346A (en) Medication for treating rhinitis and tympanitis, and preparation method
CN101259165A (en) Chaihuang preparations and producing method thereof
CN105902910A (en) Respiratory tract infection treating drop for pediatric nursing and preparation method thereof
CN105362888A (en) Medicine for treating allergic rhinitis
CN103142973B (en) Medicament for treating neurasthenia
CN108339020A (en) A kind of preparation method of three forks hardship injection
CN103142980A (en) Medicament for treating infantile cough
CN103157085A (en) Drug for treating fracture

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: HU RONG

Free format text: FORMER OWNER: YANG JUAN

Effective date: 20131231

C41 Transfer of patent application or patent right or utility model
C53 Correction of patent for invention or patent application
CB03 Change of inventor or designer information

Inventor after: Hu Rong

Inventor before: Yang Juan

COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 272501 JINING, SHANDONG PROVINCE TO: 272025 JINING, SHANDONG PROVINCE

Free format text: CORRECT: INVENTOR; FROM: YANG JUAN TO: HU RONG

TA01 Transfer of patent application right

Effective date of registration: 20131231

Address after: Supply road 272025 in Shandong province Jining City District No. 12 Jining Maternal and Child Health-Care Hospital of Pediatrics

Applicant after: Hu Rong

Address before: 272501 Shandong province Dehui Wenshang County Road No. 2

Applicant before: Yang Juan

C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140205

Termination date: 20160322

CF01 Termination of patent right due to non-payment of annual fee